FDA 483 - Hovione FarmaCiencia SA - June 28, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Hovione Farmaciencia SA, a drug manufacturer in Loures, Lisbon, Portugal, was cited for multiple significant deficiencies during an FDA inspection. Observations included inadequately qualified production equipment, insufficient investigation of manufacturing discrepancies, and a failure to maintain adequate production and process control procedures. Additionally, the firm was cited for issues with instrument calibration and qualification, and for not verifying the reliability of raw material supplier analyses.
ID · 49bc3803-2ab7-4e81-b726-8119a4440306